Oral and Intravenous Ibandronate in the Management of Postmenopausal Osteoporosis: A Comprehensive Review

E-ISSN： 1873-4286|11|28|3711-3728

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.28, 2005-11, pp. : 3711-3728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibandronate: A Review of its Use in the Management of Postmenopausal Osteoporosis

By Frampton James E. Perry Caroline M.

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2683-2707

Adis International

Access to resources Recommend Favorite

Intravenous Ibandronate: In the Treatment of Osteoporosis

By Croom Katherine F. Scott Lesley J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1593-1601

Adis International

Access to resources Recommend Favorite

Oral ibandronate: a less frequently administered therapeutic option for postmenopausal osteoporosis

By Reginster Jean-Yves

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2301-2313

Informa Healthcare

Access to resources Recommend Favorite

Review of ibandronate in the treatment of osteoporosis

By Chapurlat Roland D Delmas Pierre D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Treating Osteoporosis with Bisphosphonates and Addressing Adherence: A Review of Oral Ibandronate

By Chesnut Charles H.

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1351-1359

Adis International

Access to resources Recommend Favorite